Ventriculoperitoneal Shunt Complications in the European Idiopathic Normal Pressure Hydrocephalus Multicenter Study.


Journal

Operative neurosurgery (Hagerstown, Md.)
ISSN: 2332-4260
Titre abrégé: Oper Neurosurg (Hagerstown)
Pays: United States
ID NLM: 101635417

Informations de publication

Date de publication:
01 07 2019
Historique:
received: 12 08 2017
accepted: 28 07 2018
pubmed: 1 9 2018
medline: 24 9 2020
entrez: 1 9 2018
Statut: ppublish

Résumé

Ventriculoperitoneal shunt (VP-shunt) is the standard of treatment for idiopathic normal pressure hydrocephalus (iNPH). However, a thorough investigation of VP-shunt complications in this population is lacking. To present the analysis and the rates of complications progressively occurring during the first year after shunt surgery in the patients with iNPH included in the European multicenter (EU-iNPH) study. Patients (n = 142) were prospectively included in the EU-iNPH study by 13 institutions. All patients received a programmable VP-shunt. One hundred fifteen patients completed the 12-mo follow-up. Reexaminations were performed 1, 3, and 12 mo after surgery. Data regarding symptomatic over- or underdrainage, infections, malposition, subdural collections, and shunt surgery were collected and analyzed. Thirty patients (26%) experienced symptoms due to shunt underdrainage. Symptomatic overdrainage was reported in 10 (9%). Shunt adjustments were made in 43 (37%). Shunt malposition was recognized as the primary cause of shunt malfunction in 8 (7%), while only 1 infection (0.9%) occurred. Subdural hematoma was diagnosed in 7 (6%) and was treated by increasing the opening pressure of the valve in 5 patients. Hygroma was diagnosed in 10 (9%), requiring surgery in 1 patient. Overall, 17 patients (15%) underwent 19 shunt surgeries. The advances in valve technology, a careful opening pressure setting, and rigorous follow-up allow a significant reduction of complications, which can be usually managed nonsurgically within the first 3 to 6 mo.

Sections du résumé

BACKGROUND
Ventriculoperitoneal shunt (VP-shunt) is the standard of treatment for idiopathic normal pressure hydrocephalus (iNPH). However, a thorough investigation of VP-shunt complications in this population is lacking.
OBJECTIVE
To present the analysis and the rates of complications progressively occurring during the first year after shunt surgery in the patients with iNPH included in the European multicenter (EU-iNPH) study.
METHODS
Patients (n = 142) were prospectively included in the EU-iNPH study by 13 institutions. All patients received a programmable VP-shunt. One hundred fifteen patients completed the 12-mo follow-up. Reexaminations were performed 1, 3, and 12 mo after surgery. Data regarding symptomatic over- or underdrainage, infections, malposition, subdural collections, and shunt surgery were collected and analyzed.
RESULTS
Thirty patients (26%) experienced symptoms due to shunt underdrainage. Symptomatic overdrainage was reported in 10 (9%). Shunt adjustments were made in 43 (37%). Shunt malposition was recognized as the primary cause of shunt malfunction in 8 (7%), while only 1 infection (0.9%) occurred. Subdural hematoma was diagnosed in 7 (6%) and was treated by increasing the opening pressure of the valve in 5 patients. Hygroma was diagnosed in 10 (9%), requiring surgery in 1 patient. Overall, 17 patients (15%) underwent 19 shunt surgeries.
CONCLUSION
The advances in valve technology, a careful opening pressure setting, and rigorous follow-up allow a significant reduction of complications, which can be usually managed nonsurgically within the first 3 to 6 mo.

Identifiants

pubmed: 30169650
pii: 5087981
doi: 10.1093/ons/opy232
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-102

Informations de copyright

Copyright © 2018 by the Congress of Neurological Surgeons.

Auteurs

Alberto Feletti (A)

Department of Neurosciences, Unit of Neurosurgery, NOCSAE Modena Hospital, Modena, Italy.

Domenico d'Avella (D)

Department of Neurosciences, Academic Neurosurgery, University of Padova, Padova, Italy.

Carsten Wikkelsø (C)

Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Petra Klinge (P)

Department of Neurosurgery, The Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island.

Per Hellström (P)

Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Jos Tans (J)

Department of Neurology, Medical Centre Haaglanden, The Hague, The Netherlands.

Michael Kiefer (M)

Department of Neurosurgery, Saarland University, Homburg-Saar, Germany.

Ulrich Meier (U)

Department of Neurosurgery. Akademisches Lehrkrankenhaus der Freien Universität Berlin. Krankenhaus Berlin-Marzahn, Berlin, Germany.

Johannes Lemcke (J)

Department of Neurosurgery. Akademisches Lehrkrankenhaus der Freien Universität Berlin. Krankenhaus Berlin-Marzahn, Berlin, Germany.

Vincenzo Paternò (V)

Department of Neurosurgery, International Neuroscience Institute Hannover, Hannover, Germany.

Lennart Stieglitz (L)

Department of Neurosurgery, International Neuroscience Institute Hannover, Hannover, Germany.

Martin Sames (M)

Department of Neurosurgery, Masaryk Hospital, Usti nad Labem, The Czech Republic.

Karel Saur (K)

Department of Neurosurgery, Masaryk Hospital, Usti nad Labem, The Czech Republic.

Mariann Kordás (M)

National Institute of Neurosurgery, Budapest, Hungary.

Dusan Vitanovic (D)

National Institute of Neurosurgery, Budapest, Hungary.

Andreu Gabarrós (A)

Hospital Universitari de Bellvitge, Neurosurgery Department.

Feixa Llarga (F)

L'Hospitalet de Llobregat, Barcelona, Spain.

Michael Triffaux (M)

Service de Neurochirurgie. Clinique au Jardin Botanique 32, Brussels, Belgium.

Alain Tyberghien (A)

Service de Neurochirurgie. Clinique au Jardin Botanique 32, Brussels, Belgium.

Marianne Juhler (M)

Neurokirurgisk Klinik NK 2092, Memory Disorders Research Unit, The Neuroscience Center, N6702, Rigshospitalet, Copenhagen, Denmark.

Stehen Hasselbalch (S)

Neurokirurgisk Klinik NK 2092, Memory Disorders Research Unit, The Neuroscience Center, N6702, Rigshospitalet, Copenhagen, Denmark.

Kristina Cesarini (K)

Neurologiska kliniken, Akademiska Sjukhuset, Uppsala, Sweden.

Katarina Laurell (K)

Neurologiska kliniken, Akademiska Sjukhuset, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH